Neurizon Therapeutics LimitedASX: NUZ

Phase I Trial at RAH Meets Safety & Cancer Marker End Points

· Issued by Neurizon Therapeutics Limited

Filed with ASX ·

On 6ix: 6ix.com/news/phase-i-trial-at-rah-meets-safety-and-cancer-marker-end-points

6ix hasn’t read this filing yet.

Neurizon Therapeutics Limited on 6ix